Eagle Pharmaceuticals Operating Expenses 2011-2025 | EGRX

Annual Operating Expenses Eagle Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	113 M	105 M	104 M	82.6 M	48 M	26.1 M	14.8 M	19.2 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
113 M	14.8 M	64.1 M

Quarterly Operating Expenses Eagle Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.6 M	47.5 M	37.6 M	-	32.9 M	59.1 M	44.3 M	-	38.1 M	44.2 M	44.1 M	-	25.5 M	27.3 M	30.5 M	-	16.1 M	14.3 M	16.2 M	12.2 M	11.9 M	8.77 M	8.61 M	8.56 M	15 M	3.82 M	6.79 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
59.1 M	3.82 M	26 M

Operating Expenses of other stocks in the Drug manufacturers industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	71.8 M	-	-	$ 142 M	USA
Assertio Holdings ASRT	133 M	$ 0.74	-3.16 %	$ 52.6 M	USA
Aerie Pharmaceuticals AERI	213 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	197 M	$ 1.68	-3.51 %	$ 181 M	Canada
AcelRx Pharmaceuticals ACRX	40.3 M	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	38.9 M	-	0.86 %	$ 117 M	USA
Cronos Group CRON	154 M	$ 3.09	-5.45 %	$ 1.63 B	Canada
Agile Therapeutics AGRX	30.5 M	-	10.11 %	$ 58.2 M	USA
Aurora Cannabis ACB	183 M	$ 5.22	-3.43 %	$ 86.3 M	Canada
Catalent CTLT	512 M	-	-	$ 11.5 B	USA
Calliditas Therapeutics AB (publ) CALT	213 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	106 M	-	2.45 %	$ 38.1 M	Canada
DURECT Corporation DRRX	44.6 M	-	-	$ 50.1 M	USA
Endo International plc ENDP	763 M	-	-	$ 28.9 M	Irlanda
Emergent BioSolutions EBS	558 M	$ 11.73	2.71 %	$ 601 M	USA
Evoke Pharma EVOK	12.6 M	$ 10.97	0.18 %	$ 36.7 M	USA
Athenex ATNX	96.7 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	196 M	$ 21.42	0.28 %	$ 2.04 B	France
Evolus EOLS	107 M	$ 7.13	1.21 %	$ 442 M	USA
Harrow Health HROW	90.1 M	$ 46.05	-2.15 %	$ 1.5 B	USA
China Pharma Holdings CPHI	2.6 M	$ 1.53	-1.92 %	$ 26.7 M	China
Bausch Health Companies BHC	4.96 B	$ 6.8	-1.81 %	$ 2.48 B	Canada
Lannett Company LCI	209 M	-	1.15 %	$ 7.11 M	USA
Organogenesis Holdings ORGO	368 M	$ 4.89	1.45 %	$ 644 M	USA
OrganiGram Holdings OGI	41.4 M	$ 1.84	-4.43 %	$ 402 M	Canada
Cumberland Pharmaceuticals CPIX	35.2 M	$ 2.95	16.6 %	$ 41.5 M	USA
Pacira BioSciences PCRX	279 M	$ 26.59	1.12 %	$ 1.23 B	USA
Neoleukin Therapeutics NLTX	55.6 M	-	-	$ 193 M	Canada
Rockwell Medical RMTI	31.1 M	$ 0.9	-2.76 %	$ 21 M	USA
Solid Biosciences SLDB	130 M	$ 5.81	-1.11 %	$ 237 M	USA
PetIQ PETQ	138 M	-	1.64 %	$ 400 M	USA
Sonoma Pharmaceuticals SNOA	9.18 M	$ 3.44	-4.18 %	$ 4.27 M	USA
Relmada Therapeutics RLMD	104 M	$ 4.07	0.25 %	$ 123 M	USA
Jupiter Wellness JUPW	39.6 M	-	-	$ 33.6 M	USA
Perrigo Company plc PRGO	1.43 B	$ 13.0	-1.03 %	$ 1.79 B	USA
ProPhase Labs PRPH	47.1 M	$ 0.11	-4.97 %	$ 1.74 M	USA
Radius Health RDUS	304 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	22.5 M	-	-4.76 %	$ 65.3 M	USA
Sundial Growers SNDL	102 K	$ 2.08	-5.96 %	$ 3.37 M	Canada
OptiNose OPTN	129 M	-	-	$ 1.08 B	USA
Veru VERU	44 M	$ 2.46	1.6 %	$ 332 M	USA
PLx Pharma PLXP	44.2 M	-	-27.8 %	$ 2.56 M	USA
SCYNEXIS SCYX	67.5 M	$ 0.64	-1.5 %	$ 30.6 M	USA
cbdMD YCBD	28.9 M	$ 1.55	28.75 %	$ 6.68 M	USA
Tricida TCDA	153 M	-	-	$ 3.25 M	USA
Tilray TLRY	1.52 B	$ 11.11	-8.58 %	$ 6.87 B	Canada
TherapeuticsMD TXMD	9.82 M	$ 1.74	-0.86 %	$ 18.2 M	USA
Zomedica Corp. ZOM	14.1 M	-	-0.21 %	$ 98 M	USA
Viatris VTRS	4.88 B	$ 11.68	0.26 %	$ 14.2 B	USA